Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument.,Journal of Clinical Pharmacy and Therapeutics

当前位置： X-MOL 学术 › J. Clin. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument.
Journal of Clinical Pharmacy and Therapeutics ( IF 2.1 ) Pub Date : 2020-07-24 , DOI: 10.1111/jcpt.13213
Yahui Yu _{1,

2} , Hui Yang ₁ , Xiaojia Yu ₁ , Xiaopeng Hu ₃ , Wei Wang ₃ , Xiaoyong Yang ₃ , Hang Liu ₃ , Liang Ren ₃ , Xiaodong Zhang ₃ , Xin Feng ₂ , Lihong Liu ₁

Affiliation

Pneumocystis jiroveci (P jiroveci) is an important opportunistic fungus and causes pneumocystis jiroveci pneumonia (PJP) in kidney transplant recipients (KTRs). By using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument, the objective of this study was to evaluate the quality of PJP prophylaxis clinical practice guidelines (CPGs), and to help develop, update or improve guideline.

中文翻译：

使用 AGREE II 仪器对肺孢子虫肺炎 (PJP) 预防临床实践指南的质量和内容进行批判性评估。

耶氏肺孢子菌( P jiroveci ) 是一种重要的机会性真菌，可引起肾移植受者 (KTR) 的肺孢子虫肺炎 (PJP)。通过使用研究和评估指南评估 (AGREE) II 工具，本研究的目的是评估 PJP 预防临床实践指南 (CPG) 的质量，并帮助制定、更新或改进指南。

更新日期：2020-07-24

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南